A peer-reviewed, evidence-based journal that promotes clinical development and metabolic insights in total bariatric patient care for the healthcare professional
Issue link: https://bariatrictimes.epubxp.com/i/651228
C l i n i c a l D e v e l o p m e n t s a n d M e t a b o l i c I n s i g h t s i n T o t a l B a r i a t r i c P a t i e n t C a r e Volume 13, Number 3 March 2016 A P e e r - R e v i e w e d P u b l i c a t i o n W W W . B A R I A T R I C T I M E S . C O M LIKE us on Facebook • FOLLOW us on Twitter • CONNECT with us on LinkedIn Presorted Standard U.S. Postage PAID Lebanon Junction, KY Permit #344 VISIT BARIATRIC TIMES DURING SAGES—BOOTH #300! E DITORIAL MESSAGES . ...............3 Guest Editorial from Dr. Jaime Ponce: The Landscape of Bariatrics: A Discussion on the Role of Intragastric Balloons, Evaluating Case Growth, and Determining R ealistic Needs for the Future A Message from Dr. Christopher Still: Intragastric Balloons May Help Individuals with Obesity Reach the Important Goal of Modest Weight Loss, Improve Obesity-Related Comorbidities Also Inside CASE REPORT ..........................10 Late Onset Abdominal Pain After Gastric Bypass Due to a Rare Diagnosis—Jejuno-Jejunostomy Volvulus SPOTLIGHT ON SURGICAL FELLOWSHIPS ..........................22 An Update from the Foundation for Surgical Fellowships: Growing Need Requires Broader Support MEDICAL METHODS IN OBESITY TREATMENT .............................23 Obesity Medicine 2016 is the Leading Conference for the Advancement of Clinical Obesity Medicine NEWS AND TRENDS .................24 Page 19 COLUMN EDITOR Stephanie B. Jones, MD THIS MONTH: OBESITY AS A FOCUS IN ANESTHESIOLOGY RESEARCH BETWEEN 2000 AND 2014: An Unmet Need? INTRODUCTION The prevalence of obesity is increasing worldwide, posing a special challenge for anesthesiologists, surgeons, and the entire perioperative care team as an increasing number of surgical patients with obesity will require anesthesia and surgical services. Patients with obesity often have multiple comorbid conditions, including sleep disordered breathing and metabolic syndrome, complicating the clinical presentation and management. Physiologic changes secondary to obesity, such as decreased functional residual capacity and expiratory reserve volume that lead to increased work of breathing, oxygen consumption, CO 2 production, and ventilation- perfusion mismatching, must be taken into account when preparing the perioperative plan. A N E S T H E T I C A S P E C T S o f Ba r i a t r i c S u r g e r y ITunes Google (Android) Download the BT app for your mobile device! Scan this QR code with your QR reader for the digital edition of Bariatric Times. CALENDAR OF EVENTS ................30 CARTOON CORNER ......................30 MARKETPLACE ...........................31 AD INDEX ....................................31 Page 13 EMERGING TECHNOLOGIES BACKGROUND The use of intragastric balloons for the treatment of obesity in the United States dates back to 1985 when the United States Food and Drug Administration (FDA) approved the Garren-Edwards Gastric Bubble (American Edwards Laboratories, Irvine, California), a cylindrical-shaped device that was inserted into the stomach through the mouth and then filled with 220cc of air. The device was meant to be left in the stomach for 3 to 4 months and then removed. After the product's approval, prospective, randomized, clinical trials showed that its use did not result in significantly more weight loss than diet and behavioral modification alone. 1 It was also associated with a significant number of clinical complications that included erosions, migrations, and bowel obstructions. 2 In 1992, the manufacturer (now Edwards Lifesciences) took the device off the market voluntarily. INTRAGASTRIC BALLOONS: Closing the Gap on Weight Loss Treatment Options JAIME PONCE, MD, FACS, FASMBS Chattanooga Bariatrics, Chattanooga, Tennessee by INGRID MORENO-DUARTE, MD, and ROMAN SCHUMANN, MD